Table 3.
Clinical data obtained from the included studies.
| Study | Follow-Up | SR Ti (%) |
SR Zr/TZ (%) |
MBL Ti (mm) | MBL Zr or TZ (mm) | 1 or 2 Pieces | BoP Ti (%) | BoP TZ/Zr (%) | Mucositis | Peri-Implantitis | PD Ti | PD Zr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Koller et al., 2020 | 80 m | 93.3 | 87.5 (Zr) | −1.17 | −1.38 (Zr) | 2 | 12.6 | 16.4 (Zr) | NR | 1 Ti was removed after 80 m | NR | NR |
| Muller et al., 2015 | 5 y | 92.6 | 95.8 (TZ) | −0.61 | −0.60 (TZ) | 2 | NR | NR | NR | 1 Ti/1 TZ | NR | NR |
| Ioannidis et al., 2015 | 3 y | 97.3 | 98.7 (TZ) | −0.31 | −0.40 (TZ) | 2 | 20 | 13.8 (TZ) | 10 Ti/8 TZ | 2 TZ | 2.9 mm | 2.6 mm |
| Tolentino et al., 2015 | 1 y | 100 | 100 (TZ) | −0.35 | −0.32 (TZ) | NR | 10 | 10 (TZ) | NR | NR | 3.051 mm | 3.1 mm (TZ) |
| Osman et al., 2013 | 1 y | 95.8 | 90.9 (Zr) | −0.18 | −0.42 (Zr) | 1 | NR | NR | NR | NR | NR | NR |
| Al-Nawas et al., 2011 | 1 y | 97.8 | 98.9 (TZ) | −0.31 | −0.34 (ZT) | NR | 94.5 | 97.7 (TZ) | NR | 1 Ti/1 TZ | NR | NR |
| Siddiqi et al., 2013 | 1 y | 98.6 | 91.2 (Zr) | −0.125 | −0.25 (Zr) | 1 | NR | NR | 0 | 0 | 1.6 mm | 2.2 mm |
NR, not reported; SR, survival rate; BoP, bleeding on probing; MBL, marginal bone loss; PD, probing in-depth; Zr, zirconia; TZ, titanium–zirconium; Ti, titanium; m, months; y, year(s).